[Prophylaxis and treatment for recurrent hepatitis C virus after liver transplantation].
Sugawara
Yasuhiko
Y
Artifical Organ & Transplantation Surgery, University of Tokyo.
Makuuchi
Masatoshi
M
D000998:Antiviral Agents / Q000627:therapeutic use*; D016174:Hepacivirus; D006526:Hepatitis C / Q000188:drug therapy / Q000517:prevention & control*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage; D016031:Liver Transplantation; D011183:Postoperative Complications / Q000517:prevention & control*; D011994:Recombinant Proteins; D012254:Ribavirin / Q000008:administration & dosage; D055502:Secondary Prevention; D014019:Tissue Donors
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D012254:Ribavirin